S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
7 Stocks That Will Drive the Weight Loss Drugs Market
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
7 Stocks That Will Drive the Weight Loss Drugs Market
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
7 Stocks That Will Drive the Weight Loss Drugs Market
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
7 Stocks That Will Drive the Weight Loss Drugs Market
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:CHEK

Check-Cap (CHEK) Stock Price, News & Analysis

$3.11
+0.36 (+13.09%)
(As of 03/28/2024 ET)
Today's Range
$2.51
$3.45
50-Day Range
$1.87
$3.11
52-Week Range
$1.25
$4.63
Volume
439,130 shs
Average Volume
259,476 shs
Market Capitalization
$18.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

Check-Cap MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
125.1% Upside
$7.00 Price Target
Short Interest
Healthy
0.78% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.41mentions of Check-Cap in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.54) to ($1.63) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.84 out of 5 stars

Medical Sector

679th out of 938 stocks

X - Ray Apparatus & Tubes Industry

5th out of 6 stocks

CHEK stock logo

About Check-Cap Stock (NASDAQ:CHEK)

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

CHEK Stock Price History

CHEK Stock News Headlines

Check-Cap (CHEK) Scheduled to Post Earnings on Friday
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Why Is Check-Cap (CHEK) Stock Up 44% Today?
StockNews.com Initiates Coverage on Check-Cap (NASDAQ:CHEK)
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Larger than expected salary cap means more space for Jaguars
Check Cap Ltd (CHEK)
SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD
Check-Cap Board of Directors Issues Letter to Shareholders
Check-Cap: Q3 Earnings Insights
Check-Cap GAAP EPS of -$0.44
Check-Cap Posts Narrower Loss In Q3 - Quick Facts
Check-Cap Ltd CHEK
Notice of Extraordinary General Meeting of Shareholders
Kazakhstan Aims to Cut Loan-Rate Cap
See More Headlines
Receive CHEK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/27/2023
Today
3/28/2024
Next Earnings (Estimated)
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
X - ray apparatus & tubes
Sub-Industry
N/A
Current Symbol
NASDAQ:CHEK
Employees
85
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.00
High Stock Price Target
$7.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+125.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-19,110,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$8.57 per share

Miscellaneous

Free Float
5,822,000
Market Cap
$18.19 million
Optionable
Not Optionable
Beta
0.21
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Alex Ovadia (Age 62)
    CEO & Director
    Comp: $409.35k
  • Dr. Yoav Kimchy Ph.D. (Age 63)
    Founder & Chief Technology Officer
    Comp: $362.65k
  • Ms. Mira Rosenzweig (Age 52)
    Chief Financial Officer
    Comp: $287.99k
  • Mr. Joshua Belkar (Age 55)
    Vice President of Operations
    Comp: $269.57k
  • Ms. Noa Reshef M.B.A.
    Director of Human Resources

CHEK Stock Analysis - Frequently Asked Questions

Should I buy or sell Check-Cap stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Check-Cap in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CHEK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CHEK, but not buy additional shares or sell existing shares.
View CHEK analyst ratings
or view top-rated stocks.

What is Check-Cap's stock price target for 2024?

1 analysts have issued 1-year price objectives for Check-Cap's shares. Their CHEK share price targets range from $7.00 to $7.00. On average, they predict the company's share price to reach $7.00 in the next year. This suggests a possible upside of 125.1% from the stock's current price.
View analysts price targets for CHEK
or view top-rated stocks among Wall Street analysts.

How have CHEK shares performed in 2024?

Check-Cap's stock was trading at $2.08 at the beginning of the year. Since then, CHEK stock has increased by 49.5% and is now trading at $3.11.
View the best growth stocks for 2024 here
.

Are investors shorting Check-Cap?

Check-Cap saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 40,600 shares, an increase of 185.9% from the February 29th total of 14,200 shares. Based on an average daily volume of 228,100 shares, the short-interest ratio is presently 0.2 days. Approximately 0.8% of the company's stock are short sold.
View Check-Cap's Short Interest
.

When is Check-Cap's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our CHEK earnings forecast
.

How were Check-Cap's earnings last quarter?

Check-Cap Ltd. (NASDAQ:CHEK) released its quarterly earnings results on Monday, November, 27th. The medical research company reported ($0.44) EPS for the quarter, beating the consensus estimate of ($0.83) by $0.39.

When did Check-Cap's stock split?

Check-Cap shares reverse split before market open on Friday, November 25th 2022. The 1-20 reverse split was announced on Friday, November 25th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Check-Cap own?
When did Check-Cap IPO?

Check-Cap (CHEK) raised $13 million in an initial public offering (IPO) on Thursday, February 19th 2015. The company issued 1,200,000 shares at a price of $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group served as the underwriters for the IPO and Feltl and Company was co-manager.

Who are Check-Cap's major shareholders?

Check-Cap's stock is owned by a variety of institutional and retail investors. Top institutional investors include Nantahala Capital Management LLC (0.00%) and Dimensional Fund Advisors LP (0.00%).

How do I buy shares of Check-Cap?

Shares of CHEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CHEK) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners